Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Diagnostics and Therapeutics for HIV Markets, 2017-2023 - ResearchAndMarkets.com

Research and Markets
Posted on: 01 Nov 18

The "Diagnostics and Therapeutics for HIV: Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report organizes information from diverse sources into sections, including an overview, industry structure, diagnostic test type, treatment by drug categories, leading drug profiles and historic drug sales, regulations, reimbursements and patents.

The scope of this report includes an overview of the global market scenario for diagnosis and treatments of HIV, with base year data from 2017, estimations for 2018 and forecasts for 2023 using projections of CAGR during the forecast period.

Market data in terms of value is provided at global, regional and country levels for treatments by drug categories. Market data for HIV diagnostics is provided for regional levels, with details on test types. Estimated values are based on companies' total revenues.

The report forecasts the global market for HIV therapeutics by drug class and discusses market data for nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), single tablet regimen fixed-dose combination (STR FDC), HIV integrase stand transfer inhibitors (INSTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). The enzyme inhibitor drug class has been excluded when calculating the global HIV therapeutics market, as there are no late-stage pipeline molecules.

Diagnostic tests such as antigen- and antibody-based tests, CD4 tests and viral load tests are detailed with current and forecasted market data. Antigen- and antibody-based tests cover enzyme-linked immunosorbent assay (ELISA) tests, enzyme immunoassay (EIA) tests, rapid tests and NAT tests; CD4 tests include tests conducted to monitor the CD4 load; and viral load tests include all PCR-based tests.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary And Highlights

Chapter 3 Overview

Chapter 4 Global Industry Trends

Chapter 5 Global HIV Therapeutics Market

Chapter 6 HIV Therapeutics Market By ARV Drug Categories

Chapter 7 Leading Drugs In The HIV Therapeutics Market

Chapter 8 HIV Diagnostics Market

Chapter 9 Pipeline Analysis

Chapter 10 Regulatory And Reimbursement Structure

Chapter 11 Competitive Landscape And Key Developments

Chapter 12 Company Profiles

  • Abbott Laboratories
  • Abbvie Inc.
  • Agilent Technologies Inc.
  • Aurobindo Pharma Ltd.
  • Becton, Dickinson And Co.
  • Bio-Rad Laboratories Inc.
  • Bristol-Myers Squibb Co.
  • Cepheid Inc.
  • Gilead Sciences Inc.
  • Glaxosmithkline Plc
  • Hoffmann-La Roche Inc.
  • Hologic Inc.
  • Janssen Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Meridian Life Science Inc.
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Viiv Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/cpmmsj/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005940/en/

Business Wire
www.businesswire.com

Last updated on: 01/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.